These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2112473

  • 1. Selective chemoprophylaxis guided by multifactorial analysis in superficial bladder cancer.
    Vera-Donoso CD, Llopis B, Oliver F, Gallego J, Ruiz J, Vidal J, Jiménez Cruz JF.
    Eur Urol; 1990; 17(3):219-22. PubMed ID: 2112473
    [Abstract] [Full Text] [Related]

  • 2. [Directed chemotherapy in superficial carcinoma of the bladder conditioned by the knowledge of recurrence factors].
    Oliver F, Llopis B, Vera C, Domínguez C, Vidal J, Gallego J, Jiménez JF.
    Actas Urol Esp; 1989; 13(1):41-3. PubMed ID: 2496584
    [Abstract] [Full Text] [Related]

  • 3. Crossed chemoprophylaxis assay between adriamycin and cis-platinum in recurrent superficial bladder tumor.
    Llopis B, Gallego J, Mompó JA, Boronat F, Alonso M, Moreno B, Jiménez JF.
    Eur Urol; 1986; 12(4):253-6. PubMed ID: 3091370
    [Abstract] [Full Text] [Related]

  • 4. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients].
    Llopis B, Gallego J, Boronat F, Moreno B, Mompó JA, Jiménez JF.
    Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589
    [No Abstract] [Full Text] [Related]

  • 5. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin].
    Llopis B, Sánchez A, Boronat F, Gallego J, Moreno B, Alonso M, Martínez R, Vera CD, Jiménez JF.
    Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravesical chemotherapy.
    Prout GR.
    Prog Clin Biol Res; 1984 Apr; 162B():125-50. PubMed ID: 6438639
    [No Abstract] [Full Text] [Related]

  • 8. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001 Apr; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA, Jiménez León J, Martínez-Piñeiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P.
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term versus short-term doxorubicin hydrochloride instillation after transurethral resection of superficial bladder cancer.
    Flamm J.
    Eur Urol; 1990 Mar; 17(2):119-24. PubMed ID: 2178939
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.